AAV-mediated gene therapy for retinal disorders: from mouse to man

Gene Therapy
Prateek K BuchR R Ali

Abstract

A wide range of retinal disorders can potentially be treated using viral vector-mediated gene therapy. The most widely used vectors for ocular gene delivery are based on adeno-associated virus (AAV), because they elicit minimal immune responses and mediate long-term transgene expression in a variety of retinal cell types. Proof-of-concept experiments have demonstrated the efficacy of AAV-mediated transgene delivery in a number of animal models of inherited and acquired retinal disorders. Following extensive preclinical evaluation in large animal models, gene therapy for one form of inherited retinal degeneration due to RPE65 deficiency is now being tested in three concurrent clinical trials. Here, we review different approaches for treating inherited retinal degenerations and more common acquired retinal disorders using AAV-based vectors.

References

Dec 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·M M LaVailR H Steinberg
Jun 1, 1994·Journal of Virological Methods·M GentileH R Gelderblom
May 1, 1996·Human Molecular Genetics·R R AliS S Bhattacharya
Sep 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·H MiyoshiI M Verma
Feb 11, 1998·Human Gene Therapy·R R AliA J Thrasher
May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·A Di PoloA J Aguayo
Jan 12, 1999·Nature Medicine·C SummerfordR J Samulski
Sep 29, 1999·Journal of Medical Virology·K ErlesJ R Schlehofer
Jan 11, 2000·Developments in Ophthalmology·A D Dick
May 30, 2001·Current Opinion in Genetics & Development·D A BessantS S Bhattacharya
Nov 16, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·F Q LiangJ Bennett
Feb 7, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Vibha AnandJean Bennett
Feb 21, 2002·Vision Research·B ChangJ R Heckenlively
Apr 9, 2002·Human Gene Therapy·Andrew J LoteryBeverly L Davidson
Jun 22, 2002·American Journal of Human Genetics·Susanne KohlBernd Wissinger
Aug 6, 2002·Survey of Ophthalmology·Sascha FauserFrank Schüttauf
Oct 16, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Alberto AuricchioMichael J Tolentino
Nov 5, 2002·Methods : a Companion to Methods in Enzymology·Keith R G MartinHarry A Quigley
Mar 27, 2003·Investigative Ophthalmology & Visual Science·Kristina NarfströmP Elizabeth Rakoczy
Apr 15, 2003·The Journal of Heredity·K NarfströmR Bragadóttir
Aug 9, 2003·Molecular Therapy : the Journal of the American Society of Gene Therapy·Alexander J SmithRobin R Ali
Sep 2, 2003·The Journal of Gene Medicine·Frank C SchlichtenbredeRobin R Ali
Sep 12, 2003·Trends in Immunology·Rosetta PedottiStephen J Galli
Sep 23, 2003·Nature Medicine·Giovanni Di PasqualeJohn A Chiorini
Dec 11, 2003·Molecular and Cellular Neurosciences·Przemyslaw S SapiehaAdriana Di Polo
Feb 5, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Nadine S DejnekaJean Bennett
Sep 8, 2004·The Journal of Gene Medicine·Rossella RotaMaurizio C Capogrossi
Nov 10, 2004·Eye·N N OsborneJ Melena
Feb 25, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·J M I MalikS Kügler

❮ Previous
Next ❯

Citations

Feb 22, 2012·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·P Charbel IssaR E MacLaren
Jul 2, 2011·Cytotechnology·Xin-Jun Cai, Ying-Ying Xu
Aug 7, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Douglas M McCarty
Dec 22, 2009·Human Gene Therapy·Kathleen D KolstadJohn G Flannery
Aug 25, 2010·The British Journal of Ophthalmology·Melissa M LiuChi-Chao Chan
Jun 28, 2011·Postgraduate Medical Journal·Melissa M LiuChi-Chao Chan
Oct 31, 2008·American Journal of Physiology. Renal Physiology·Wei MuRichard J Johnson
Jun 2, 2011·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Raymond M SchiffelersGert Storm
Apr 18, 2009·Ophthalmic Genetics·Xue CaiMuna I Naash
Nov 27, 2015·Expert Review of Ophthalmology·Cristy A Ku, Mark E Pennesi
Apr 21, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Mauro Giacca, Serena Zacchigna
Jul 23, 2011·Experimental Eye Research·D KampikD F P Larkin
Apr 21, 2009·Progress in Retinal and Eye Research·Camiel J F BoonAnneke I den Hollander
Mar 24, 2009·Trends in Genetics : TIG·Alexander J SmithRobin R Ali
Dec 23, 2008·Trends in Molecular Medicine·Pasqualina ColellaAlberto Auricchio
Jun 12, 2013·Veterinary Ophthalmology·Caroline J Zeiss
Aug 6, 2014·Vision Research·Livia S Carvalho, Luk H Vandenberghe
Mar 15, 2011·Neurobiology of Aging·Jingsheng TuoChi-Chao Chan
May 27, 2014·Frontiers in Integrative Neuroscience·Jessica M D'AmicoMonica A Gorassini
Mar 6, 2018·British Medical Bulletin·Neruban KumaranJames W B Bainbridge
Oct 27, 2017·Artificial Cells, Nanomedicine, and Biotechnology·Maryam GhasemiNosratollah Zarghami
Aug 14, 2018·The Journal of Gene Medicine·Hongling ZhuBrian H Annex
Aug 9, 2013·Journal of Virology·Lakshmanan GovindasamyMavis Agbandje-McKenna
Mar 20, 2009·Expert Review of Cardiovascular Therapy·Nicolle Kränkel, Paolo Madeddu
Jul 4, 2019·Current Gene Therapy·Xue-Peng ZhangZhe Luo
Aug 5, 2016·Asia-Pacific Journal of Ophthalmology·Micah A ChrenekJeffrey H Boatright

❮ Previous
Next ❯

Related Concepts

Related Feeds

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.